Related Experiment Video
Updated: Aug 29, 2025

10:55
Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
19.4K
Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling
Danyel Evseev1, Domingo Miranzo-Navarro1, Ximena Fleming-Canepa1
1Department of Biological Sciences and Li Ka Shing Institute of Virology, University of Albertagrid.17089.37, Edmonton, Alberta, Canada.
Journal of Virology
|September 7, 2022
Summary
Influenza A virus NS1 proteins block human immune responses but not duck responses, revealing host-specific viral evasion strategies. This impacts understanding avian influenza virus evolution and zoonotic disease potential.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Influenza A virus nonstructural protein 1 (NS1) is a virulence factor.
- NS1 inhibits type I interferon induction, potentially by targeting the RIG-I receptor and TRIM25.
- Duck TRIM25 interaction with NS1 is uncharacterized, despite ducks being a natural reservoir.
Purpose of the Study:
- To investigate if NS1 inhibition of TRIM25 is strain-dependent and conserved in ducks.
- To compare NS1 interaction with human and duck TRIM25.
- To assess the impact on RIG-I ubiquitination and signaling in both species.
Main Methods:
- Coimmunoprecipitation and microscopy to assess NS1-TRIM25 interactions.
- Analysis of RIG-I ubiquitination and interferon promoter activity in human and duck cells.
- Use of NS1 proteins from various avian and mouse-adapted influenza A strains.
Main Results:
- Avian NS1 proteins potently inhibited human RIG-I ubiquitination and interferon production, unlike mouse-adapted PR8 NS1.
- All tested NS1 proteins suppressed interferon in infected human alveolar cells.
- Avian NS1 proteins did not suppress duck RIG-I ubiquitination or interferon production, despite interacting with duck TRIM25.
Conclusions:
- Influenza A virus NS1 proteins exhibit host-specific inhibition of the RIG-I antiviral pathway.
- Avian NS1 proteins can evade duck immune responses, contributing to their resistance to influenza.
- Understanding these host-pathogen dynamics is crucial for avian influenza surveillance and zoonotic disease prevention.
Keywords:
TRIM25avian virusescell signalingduckinfluenza virusesinterferonsreservoir hostubiquitinationviral pathogenesisMore Related Videos
Related Concept Videos
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K

